LCD/NCD Portal
Automated World Health
L29167
DIAGNOSTIC AND THERAPEUTIC ESOPHAGOGASTRODUODENOSCOPY
10/01/2011
Indications and Limitations of Coverage and/or Medical Necessity
Medicare will consider EGD(s) to be medically reasonable and necessary under the following diagnostic conditions:
• Patient has upper abdominal distress (e.g., gastroesophageal reflux disease) which persists despite an appropriate trial of symptomatic therapy.
• Patient has upper abdominal distress associated with a short history of signs and symptoms suggesting significant associated disease or illness e.g.:
o Weight loss.
o Anorexia.
o Vomiting.
o Nonsteroidal anti-inflammatory drug NSAID intake.
o Other gastric irritant intake.
• Patients over the age of 40 who have experienced a significant history of heartburn that returns after a course of symptomatic therapy.
• Patients who have dysphagia or odynophagia.
• Patient has persistent, unexplained vomiting.
• Patient has upper gastrointestinal x-ray findings of:
o Any lesion that requires biopsy for diagnosis.
o Gastric ulcer suspicious of cancer.
o Evidence of stricture or obstruction.
• To assess acute injury after caustic agent ingestion;
• When anti-reflux surgery is contemplated.
• Patient has gastrointestinal bleeding:
o In most actively bleeding patients.
o For presumed chronic blood loss and iron deficiency anemia when investigation of large bowel is negative.
Medicare will consider EGD(s) to be medically reasonable and necessary for the following therapeutic purposes:
• Treatment of bleeding lesions.
• Removal of foreign bodies.
• Sclerotherapy and/or band ligation for bleeding from esophageal or gastric varices.
• Dilatation of strictures in the upper intestinal tract.
• Removal of selected polypoid lesions.
• Placement of feeding tubes.
• Palliative therapy of stenosing neoplasms (e.g., laser, stent placement).
• Gastrointestinal bleeding may be treated with a variety of methods.
o Direct contact heater probes and hemostatic injections into or around the bleeding vessels are both effective therapy for acute bleeding.
• Foreign body removal from the stomach or esophagus is usually successful with these flexible instruments.
o The foreign bodies can be retrieved by either of two methods.
o The first method is to capture the foreign body with a snare device/grasping forceps and pull the item out with the endoscope.
o The second method is accomplished by piecemeal destruction and pushing the bolus through the esophagus into the stomach.
• Esophageal varices may be injected with a variety of sclerosing solutions.
o Eradication of varices requires, on the average, five sclerotherapy sessions, with multiple injections given during each session.
• Dilatation of strictures may be accomplished with a balloon placed through the endoscope and inflated using hydrostatic pressure.
o Bougies are rubber dilators available in various sizes up to approximately 2.0cm.
o Plastic bougies and other dilating probes are usually passed over a guide wire.
o This procedure involves placing the guide wire into the stomach through the endoscope.
o The endoscope is then withdrawn leaving the guide wire in place.
o The dilating probes and plastic bougies are then passed over the guide wire.
o After the largest dilator is used, the dilator and guide wire are removed.
o Esophageal dilation is performed after a definitive diagnosis has been established in patients exhibiting dysphagia.
o The goal in most cases is a lumenal diameter of 16-17mm which allows passage of solid food.
o A series of dilators may be passed over the guide wire to reach the goal of therapy.
Medicare will consider follow-up EGD(s) medically reasonable and necessary for the following indications:
• Biopsy surveillance of patients with Barrett’s esophagus every 12 to 24 months.
o However, if dysplasia is present, earlier surveillance intervals of from three to six months may be required.
• Follow-up of gastric ulcers to healing or satisfaction that they are benign.
• Follow-up and treatment of esophageal strictures requiring guidewire dilation.
• Follow-up of duodenal ulcer or other lesions of the upper gastrointestinal tract that have resulted in serious consequences (e.g., hemorrhage).
• Follow-up of patients having a previous gastric polypectomy for adenoma.
• Follow-up and treatment of patients with esophageal varices or bleeding lesions requiring recurrent therapy:
o Esophageal varices.
o Gastric varices.
o Angiodysplastic or watermelon stomach lesions.
o Radiation gastritis.
• Follow-up for removal of percutaneous gastrostomy tube (PEG)
• Periodic EGD is NOT usually indicated in the following situations:
o Surveillance of healed, benign disease such as gastric or duodenal ulcer or benign esophageal strictures.
o Cancer surveillance in patients with pernicious anemia, treated achalasia, or prior gastric resection.
• EGD is generally contraindicated for patients with recent myocardial infarction.
CPT/HCPCS Codes
43235 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; DIAGNOSTIC, WITH OR WITHOUT COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING (SEPARATE PROCEDURE)
43236 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE
43237 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED TO THE ESOPHAGUS
43238 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S), ESOPHAGUS (INCLUDES ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED TO THE ESOPHAGUS)
43239 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH BIOPSY, SINGLE OR MULTIPLE
43241 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH TRANSENDOSCOPIC INTRALUMINAL TUBE OR CATHETER PLACEMENT
43243 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH INJECTION SCLEROSIS OF ESOPHAGEAL AND/OR GASTRIC VARICES
43244 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH BAND LIGATION OF ESOPHAGEAL AND/OR GASTRIC VARICES
43245 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH DILATION OF GASTRIC OUTLET FOR OBSTRUCTION (EG, BALLOON, GUIDE WIRE, BOUGIE)
43246 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH DIRECTED PLACEMENT OF PERCUTANEOUS GASTROSTOMY TUBE
43247 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH REMOVAL OF FOREIGN BODY
43248 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH INSERTION OF GUIDE WIRE FOLLOWED BY DILATION OF ESOPHAGUS OVER GUIDE WIRE
43249 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH BALLOON DILATION OF ESOPHAGUS (LESS THAN 30 MM DIAMETER)
43250 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY HOT BIOPSY FORCEPS OR BIPOLAR CAUTERY
43251 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE
43255 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH CONTROL OF BLEEDING, ANY METHOD
43258 UPPER GASTROINTESTINAL ENDOSCOPY INCLUDING ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM AND/OR JEJUNUM AS APPROPRIATE; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) NOT AMENABLE TO REMOVAL BY HOT BIOPSY FORCEPS, BIPOLAR CAUTERY OR SNARE TECHNIQUE
ICD-9 Codes that Support Medical Necessity
040.2 WHIPPLE'S DISEASE
112.84 CANDIDAL ESOPHAGITIS
150.0 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS
150.1 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS
150.2 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS
150.3 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS
150.4 MALIGNANT NEOPLASM OF MIDDLE THIRD OF ESOPHAGUS
150.5 MALIGNANT NEOPLASM OF LOWER THIRD OF ESOPHAGUS
150.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED PART OF ESOPHAGUS
150.9 MALIGNANT NEOPLASM OF ESOPHAGUS UNSPECIFIED SITE
151.0 MALIGNANT NEOPLASM OF CARDIA
151.1 MALIGNANT NEOPLASM OF PYLORUS
151.2 MALIGNANT NEOPLASM OF PYLORIC ANTRUM
151.3 MALIGNANT NEOPLASM OF FUNDUS OF STOMACH
151.4 MALIGNANT NEOPLASM OF BODY OF STOMACH
151.5 MALIGNANT NEOPLASM OF LESSER CURVATURE OF STOMACH UNSPECIFIED
151.6 MALIGNANT NEOPLASM OF GREATER CURVATURE OF STOMACH UNSPECIFIED
151.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF STOMACH
151.9 MALIGNANT NEOPLASM OF STOMACH UNSPECIFIED SITE
152.0 MALIGNANT NEOPLASM OF DUODENUM
152.1 MALIGNANT NEOPLASM OF JEJUNUM
152.2 MALIGNANT NEOPLASM OF ILEUM
152.3 MALIGNANT NEOPLASM OF MECKEL'S DIVERTICULUM
152.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF SMALL INTESTINE
152.9 MALIGNANT NEOPLASM OF SMALL INTESTINE UNSPECIFIED SITE
155.0 MALIGNANT NEOPLASM OF LIVER PRIMARY
156.0 MALIGNANT NEOPLASM OF GALLBLADDER
156.1 MALIGNANT NEOPLASM OF EXTRAHEPATIC BILE DUCTS
156.2 MALIGNANT NEOPLASM OF AMPULLA OF VATER
156.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF GALLBLADDER AND EXTRAHEPATIC BILE DUCTS
156.9 MALIGNANT NEOPLASM OF BILIARY TRACT PART UNSPECIFIED SITE
157.0 MALIGNANT NEOPLASM OF HEAD OF PANCREAS
157.1 MALIGNANT NEOPLASM OF BODY OF PANCREAS
157.2 MALIGNANT NEOPLASM OF TAIL OF PANCREAS
157.3 MALIGNANT NEOPLASM OF PANCREATIC DUCT
157.4 MALIGNANT NEOPLASM OF ISLETS OF LANGERHANS
157.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF PANCREAS
157.9 MALIGNANT NEOPLASM OF PANCREAS PART UNSPECIFIED
159.8 MALIGNANT NEOPLASM OF OTHER SITES OF DIGESTIVE SYSTEM AND INTRA-ABDOMINAL ORGANS
176.3 KAPOSI'S SARCOMA GASTROINTESTINAL SITES
197.4 SECONDARY MALIGNANT NEOPLASM OF SMALL INTESTINE INCLUDING DUODENUM
197.6 SECONDARY MALIGNANT NEOPLASM OF RETROPERITONEUM AND PERITONEUM
198.89 SECONDARY MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES
202.80 OTHER MALIGNANT LYMPHOMAS UNSPECIFIED SITE
211.0 BENIGN NEOPLASM OF ESOPHAGUS
211.1 BENIGN NEOPLASM OF STOMACH
211.2 BENIGN NEOPLASM OF DUODENUM JEJUNUM AND ILEUM
211.3 BENIGN NEOPLASM OF COLON
211.4 BENIGN NEOPLASM OF RECTUM AND ANAL CANAL
211.5 BENIGN NEOPLASM OF LIVER AND BILIARY PASSAGES
211.6 BENIGN NEOPLASM OF PANCREAS EXCEPT ISLETS OF LANGERHANS
211.7 BENIGN NEOPLASM OF ISLETS OF LANGERHANS
211.8 BENIGN NEOPLASM OF RETROPERITONEUM AND PERITONEUM
211.9 BENIGN NEOPLASM OF OTHER AND UNSPECIFIED SITE IN THE DIGESTIVE SYSTEM
214.3 LIPOMA OF INTRA-ABDOMINAL ORGANS
214.9 LIPOMA UNSPECIFIED SITE
215.9 OTHER BENIGN NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE SITE UNSPECIFIED
228.04 HEMANGIOMA OF INTRA-ABDOMINAL STRUCTURES
230.1 CARCINOMA IN SITU OF ESOPHAGUS
230.2 CARCINOMA IN SITU OF STOMACH
230.3 CARCINOMA IN SITU OF COLON
230.4 CARCINOMA IN SITU OF RECTUM
230.5 CARCINOMA IN SITU OF ANAL CANAL
230.6 CARCINOMA IN SITU OF ANUS UNSPECIFIED
230.7 CARCINOMA IN SITU OF OTHER AND UNSPECIFIED PARTS OF INTESTINE
230.8 CARCINOMA IN SITU OF LIVER AND BILIARY SYSTEM
235.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF STOMACH INTESTINES AND RECTUM
235.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF LIVER AND BILIARY PASSAGES
235.4 NEOPLASM OF UNCERTAIN BEHAVIOR OF RETROPERITONEUM AND PERITONEUM
239.0 NEOPLASM OF UNSPECIFIED NATURE OF DIGESTIVE SYSTEM
251.5 ABNORMALITY OF SECRETION OF GASTRIN
261 NUTRITIONAL MARASMUS
263.0 MALNUTRITION OF MODERATE DEGREE
263.1 MALNUTRITION OF MILD DEGREE
263.2 ARRESTED DEVELOPMENT FOLLOWING PROTEIN-CALORIE MALNUTRITION
263.8 OTHER PROTEIN-CALORIE MALNUTRITION
263.9 UNSPECIFIED PROTEIN-CALORIE MALNUTRITION
280.0 IRON DEFICIENCY ANEMIA SECONDARY TO BLOOD LOSS (CHRONIC)
280.1 IRON DEFICIENCY ANEMIA SECONDARY TO INADEQUATE DIETARY IRON INTAKE
280.8 OTHER SPECIFIED IRON DEFICIENCY ANEMIAS
280.9 IRON DEFICIENCY ANEMIA UNSPECIFIED
285.1 ACUTE POSTHEMORRHAGIC ANEMIA
300.11 CONVERSION DISORDER
306.4 GASTROINTESTINAL MALFUNCTION ARISING FROM MENTAL FACTORS
307.1 ANOREXIA NERVOSA
307.50 EATING DISORDER UNSPECIFIED
307.51 BULIMIA NERVOSA
307.52 PICA
307.53 RUMINATION DISORDER
307.54 PSYCHOGENIC VOMITING
438.82 DYSPHAGIA CEREBROVASCULAR DISEASE
447.2 RUPTURE OF ARTERY
448.0 HEREDITARY HEMORRHAGIC TELANGIECTASIA
456.0 ESOPHAGEAL VARICES WITH BLEEDING
456.1 ESOPHAGEAL VARICES WITHOUT BLEEDING
456.20 ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITH BLEEDING
456.21 ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITHOUT BLEEDING
507.0 PNEUMONITIS DUE TO INHALATION OF FOOD OR VOMITUS
530.0 ACHALASIA AND CARDIOSPASM
530.10 ESOPHAGITIS UNSPECIFIED
530.11 REFLUX ESOPHAGITIS
530.12 ACUTE ESOPHAGITIS
530.13 EOSINOPHILIC ESOPHAGITIS
530.19 OTHER ESOPHAGITIS
530.20 ULCER OF ESOPHAGUS WITHOUT BLEEDING
530.21 ULCER OF ESOPHAGUS WITH BLEEDING
530.3 STRICTURE AND STENOSIS OF ESOPHAGUS
530.4 PERFORATION OF ESOPHAGUS
530.5 DYSKINESIA OF ESOPHAGUS
530.6 DIVERTICULUM OF ESOPHAGUS ACQUIRED
530.7 GASTROESOPHAGEAL LACERATION-HEMORRHAGE SYNDROME
530.81 ESOPHAGEAL REFLUX
530.82 ESOPHAGEAL HEMORRHAGE
530.83 ESOPHAGEAL LEUKOPLAKIA
530.84 TRACHEOESOPHAGEAL FISTULA
530.85 BARRETT'S ESOPHAGUS
530.86 INFECTION OF ESOPHAGOSTOMY
530.87 MECHANICAL COMPLICATION OF ESOPHAGOSTOMY
530.89 OTHER DISEASES OF ESOPHAGUS
531.00 ACUTE GASTRIC ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
531.01 ACUTE GASTRIC ULCER WITH HEMORRHAGE WITH OBSTRUCTION
531.10 ACUTE GASTRIC ULCER WITH PERFORATION WITHOUT OBSTRUCTION
531.11 ACUTE GASTRIC ULCER WITH PERFORATION WITH OBSTRUCTION
531.20 ACUTE GASTRIC ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
531.21 ACUTE GASTRIC ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
531.30 ACUTE GASTRIC ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
531.31 ACUTE GASTRIC ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
531.40 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
531.41 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH HEMORRHAGE WITH OBSTRUCTION
531.50 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH PERFORATION WITHOUT OBSTRUCTION
531.51 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH PERFORATION WITH OBSTRUCTION
531.60 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
531.61 CHRONIC OR UNSPECIFIED GASTRIC ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
531.70 CHRONIC GASTRIC ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
531.71 CHRONIC GASTRIC ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
531.90 GASTRIC ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
531.91 GASTRIC ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
532.00 ACUTE DUODENAL ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
532.01 ACUTE DUODENAL ULCER WITH HEMORRHAGE WITH OBSTRUCTION
532.10 ACUTE DUODENAL ULCER WITH PERFORATION WITHOUT OBSTRUCTION
532.11 ACUTE DUODENAL ULCER WITH PERFORATION WITH OBSTRUCTION
532.20 ACUTE DUODENAL ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
532.21 ACUTE DUODENAL ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
532.30 ACUTE DUODENAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
532.31 ACUTE DUODENAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
532.40 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
532.41 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH HEMORRHAGE WITH OBSTRUCTION
532.50 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH PERFORATION WITHOUT OBSTRUCTION
532.51 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH PERFORATION WITH OBSTRUCTION
532.60 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
532.61 CHRONIC OR UNSPECIFIED DUODENAL ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
532.70 CHRONIC DUODENAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
532.71 CHRONIC DUODENAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
532.90 DUODENAL ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
532.91 DUODENAL ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
533.00 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE WITHOUT OBSTRUCTION
533.01 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE WITH OBSTRUCTION
533.10 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH PERFORATION WITHOUT OBSTRUCTION
533.11 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH PERFORATION WITH OBSTRUCTION
533.20 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
533.21 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
533.30 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITHOUT HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
533.31 ACUTE PEPTIC ULCER OF UNSPECIFIED SITE WITHOUT HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
533.40 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE WITHOUT OBSTRUCTION
533.41 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE WITH OBSTRUCTION
533.50 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH PERFORATION WITHOUT OBSTRUCTION
533.51 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH PERFORATION WITH OBSTRUCTION
533.60 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
533.61 CHRONIC OR UNSPECIFIED PEPTIC ULCER OF UNSPECIFIED SITE WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
533.70 CHRONIC PEPTIC ULCER OF UNSPECIFIED SITE WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
533.71 CHRONIC PEPTIC ULCER OF UNSPECIFIED SITE WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
533.90 PEPTIC ULCER OF UNSPECIFIED SITE UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
533.91 PEPTIC ULCER OF UNSPECIFIED SITE UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
534.00 ACUTE GASTROJEJUNAL ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
534.01 ACUTE GASTROJEJUNAL ULCER WITH HEMORRHAGE WITH OBSTRUCTION
534.10 ACUTE GASTROJEJUNAL ULCER WITH PERFORATION WITHOUT OBSTRUCTION
534.11 ACUTE GASTROJEJUNAL ULCER WITH PERFORATION WITH OBSTRUCTION
534.20 ACUTE GASTROJEJUNAL ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
534.21 ACUTE GASTROJEJUNAL ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
534.30 ACUTE GASTROJEJUNAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
534.31 ACUTE GASTROJEJUNAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
534.40 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH HEMORRHAGE WITHOUT OBSTRUCTION
534.41 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH HEMORRHAGE WITH OBSTRUCTION
534.50 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH PERFORATION WITHOUT OBSTRUCTION
534.51 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH PERFORATION WITH OBSTRUCTION
534.60 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH HEMORRHAGE AND PERFORATION WITHOUT OBSTRUCTION
534.61 CHRONIC OR UNSPECIFIED GASTROJEJUNAL ULCER WITH HEMORRHAGE AND PERFORATION WITH OBSTRUCTION
534.70 CHRONIC GASTROJEJUNAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
534.71 CHRONIC GASTROJEJUNAL ULCER WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
534.90 GASTROJEJUNAL ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITHOUT OBSTRUCTION
534.91 GASTROJEJUNAL ULCER UNSPECIFIED AS ACUTE OR CHRONIC WITHOUT HEMORRHAGE OR PERFORATION WITH OBSTRUCTION
535.00 ACUTE GASTRITIS (WITHOUT HEMORRHAGE)
535.01 ACUTE GASTRITIS WITH HEMORRHAGE
535.10 ATROPHIC GASTRITIS (WITHOUT HEMORRHAGE)
535.11 ATROPHIC GASTRITIS WITH HEMORRHAGE
535.20 GASTRIC MUCOSAL HYPERTROPHY (WITHOUT HEMORRHAGE)
535.21 GASTRIC MUCOSAL HYPERTROPHY WITH HEMORRHAGE
535.30 ALCOHOLIC GASTRITIS (WITHOUT HEMORRHAGE)
535.31 ALCOHOLIC GASTRITIS WITH HEMORRHAGE
535.40 OTHER SPECIFIED GASTRITIS (WITHOUT HEMORRHAGE)
535.41 OTHER SPECIFIED GASTRITIS WITH HEMORRHAGE
535.50 UNSPECIFIED GASTRITIS AND GASTRODUODENITIS (WITHOUT HEMORRHAGE)
535.51 UNSPECIFIED GASTRITIS AND GASTRODUODENITIS WITH HEMORRHAGE
535.60 DUODENITIS (WITHOUT HEMORRHAGE)
535.61 DUODENITIS WITH HEMORRHAGE
535.70 EOSINOPHILIC GASTRITIS, WITHOUT MENTION OF HEMORRHAGE
535.71 EOSINOPHILIC GASTRITIS, WITH HEMORRHAGE
536.1 ACUTE DILATATION OF STOMACH
536.2 PERSISTENT VOMITING
536.3 GASTROPARESIS
536.40 GASTROSTOMY COMPLICATION UNSPECIFIED
536.41 INFECTION OF GASTROSTOMY
536.42 MECHANICAL COMPLICATION OF GASTROSTOMY
536.49 OTHER GASTROSTOMY COMPLICATIONS
536.8 DYSPEPSIA AND OTHER SPECIFIED DISORDERS OF FUNCTION OF STOMACH
537.0 ACQUIRED HYPERTROPHIC PYLORIC STENOSIS
537.1 GASTRIC DIVERTICULUM
537.2 CHRONIC DUODENAL ILEUS
537.3 OTHER OBSTRUCTION OF DUODENUM
537.4 FISTULA OF STOMACH OR DUODENUM
537.5 GASTROPTOSIS
537.6 HOURGLASS STRICTURE OR STENOSIS OF STOMACH
537.81 PYLOROSPASM
537.82 ANGIODYSPLASIA OF STOMACH AND DUODENUM (WITHOUT HEMORRHAGE)
537.83 ANGIODYSPLASIA OF STOMACH AND DUODENUM WITH HEMORRHAGE
537.84 DIEULAFOY LESION (HEMORRHAGIC) OF STOMACH AND DUODENUM
537.89 OTHER SPECIFIED DISORDERS OF STOMACH AND DUODENUM
538 GASTROINTESTINAL MUCOSITIS (ULCERATIVE)
551.3 DIAPHRAGMATIC HERNIA WITH GANGRENE
552.3 DIAPHRAGMATIC HERNIA WITH OBSTRUCTION
552.8 HERNIA OF OTHER SPECIFIED SITES WITH OBSTRUCTION
553.3 DIAPHRAGMATIC HERNIA WITHOUT OBSTRUCTION OR GANGRENE
555.0 REGIONAL ENTERITIS OF SMALL INTESTINE
555.1 REGIONAL ENTERITIS OF LARGE INTESTINE
555.2 REGIONAL ENTERITIS OF SMALL INTESTINE WITH LARGE INTESTINE
555.9 REGIONAL ENTERITIS OF UNSPECIFIED SITE
560.9 UNSPECIFIED INTESTINAL OBSTRUCTION
562.01 DIVERTICULITIS OF SMALL INTESTINE (WITHOUT HEMORRHAGE)
562.02 DIVERTICULOSIS OF SMALL INTESTINE WITH HEMORRHAGE
562.03 DIVERTICULITIS OF SMALL INTESTINE WITH HEMORRHAGE
569.62 MECHANICAL COMPLICATION OF COLOSTOMY AND ENTEROSTOMY
569.71 POUCHITIS
569.79 OTHER COMPLICATIONS OF INTESTINAL POUCH
569.82 ULCERATION OF INTESTINE
569.87 VOMITING OF FECAL MATTER
571.1 ACUTE ALCOHOLIC HEPATITIS
571.2 ALCOHOLIC CIRRHOSIS OF LIVER
571.3 ALCOHOLIC LIVER DAMAGE UNSPECIFIED
571.40 CHRONIC HEPATITIS UNSPECIFIED
571.41 CHRONIC PERSISTENT HEPATITIS
571.42 AUTOIMMUNE HEPATITIS
571.49 OTHER CHRONIC HEPATITIS
571.5 CIRRHOSIS OF LIVER WITHOUT ALCOHOL
571.6 BILIARY CIRRHOSIS
572.3 PORTAL HYPERTENSION
574.00 CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITHOUT OBSTRUCTION
574.01 CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITH OBSTRUCTION
574.10 CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITHOUT OBSTRUCTION
574.11 CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITH OBSTRUCTION
574.20 CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITHOUT OBSTRUCTION
574.21 CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITH OBSTRUCTION
574.30 CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITHOUT OBSTRUCTION
574.31 CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITH OBSTRUCTION
574.40 CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITHOUT OBSTRUCTION
574.41 CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITH OBSTRUCTION
575.0 ACUTE CHOLECYSTITIS
575.5 FISTULA OF GALLBLADDER
576.0 POSTCHOLECYSTECTOMY SYNDROME
576.4 FISTULA OF BILE DUCT
577.0 ACUTE PANCREATITIS
577.1 CHRONIC PANCREATITIS
577.2 CYST AND PSEUDOCYST OF PANCREAS
578.0 HEMATEMESIS
578.1 BLOOD IN STOOL
578.9 HEMORRHAGE OF GASTROINTESTINAL TRACT UNSPECIFIED
579.0 CELIAC DISEASE
579.1 TROPICAL SPRUE
579.2 BLIND LOOP SYNDROME
579.3 OTHER AND UNSPECIFIED POSTSURGICAL NONABSORPTION
579.4 PANCREATIC STEATORRHEA
579.8 OTHER SPECIFIED INTESTINAL MALABSORPTION
579.9 UNSPECIFIED INTESTINAL MALABSORPTION
694.0 DERMATITIS HERPETIFORMIS
710.1 SYSTEMIC SCLEROSIS
747.61 GASTROINTESTINAL VESSEL ANOMALY
750.3 CONGENITAL TRACHEOESOPHAGEAL FISTULA ESOPHAGEAL ATRESIA AND STENOSIS
750.4 OTHER SPECIFIED CONGENITAL ANOMALIES OF ESOPHAGUS
750.5 CONGENITAL HYPERTROPHIC PYLORIC STENOSIS
750.6 CONGENITAL HIATUS HERNIA
750.7 OTHER SPECIFIED CONGENITAL ANOMALIES OF STOMACH
783.0 ANOREXIA
783.21 LOSS OF WEIGHT
783.22 UNDERWEIGHT
783.3 FEEDING DIFFICULTIES AND MISMANAGEMENT
784.42 DYSPHONIA
784.43 HYPERNASALITY
784.44 HYPONASALITY
784.49 OTHER VOICE AND RESONANCE DISORDERS
784.52 FLUENCY DISORDER IN CONDITIONS CLASSIFIED ELSEWHERE
784.91 POSTNASAL DRIP
784.92 JAW PAIN
784.99 OTHER SYMPTOMS INVOLVING HEAD AND NECK
786.2 COUGH
786.50 UNSPECIFIED CHEST PAIN
786.51 PRECORDIAL PAIN
786.52 PAINFUL RESPIRATION
786.59 OTHER CHEST PAIN
786.6 SWELLING MASS OR LUMP IN CHEST
787.01 NAUSEA WITH VOMITING
787.02 NAUSEA ALONE
787.03 VOMITING ALONE
787.04 BILIOUS EMESIS
787.1 HEARTBURN
787.20 DYSPHAGIA, UNSPECIFIED
787.21 DYSPHAGIA, ORAL PHASE
787.22 DYSPHAGIA, OROPHARYNGEAL PHASE
787.23 DYSPHAGIA, PHARYNGEAL PHASE
787.24 DYSPHAGIA, PHARYNGOESOPHAGEAL PHASE
787.29 OTHER DYSPHAGIA
787.3 FLATULENCE ERUCTATION AND GAS PAIN
787.4 VISIBLE PERISTALSIS
787.5 ABNORMAL BOWEL SOUNDS
787.60 FULL INCONTINENCE OF FECES
787.61 INCOMPLETE DEFECATION
787.62 FECAL SMEARING
787.63 FECAL URGENCY
787.7 ABNORMAL FECES
787.91 DIARRHEA
789.00 ABDOMINAL PAIN UNSPECIFIED SITE
789.01 ABDOMINAL PAIN RIGHT UPPER QUADRANT
789.02 ABDOMINAL PAIN LEFT UPPER QUADRANT
789.03 ABDOMINAL PAIN RIGHT LOWER QUADRANT
789.04 ABDOMINAL PAIN LEFT LOWER QUADRANT
789.05 ABDOMINAL PAIN PERIUMBILIC
789.06 ABDOMINAL PAIN EPIGASTRIC
789.07 ABDOMINAL PAIN GENERALIZED
789.09 ABDOMINAL PAIN OTHER SPECIFIED SITE
789.30 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP UNSPECIFIED SITE
789.31 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP RIGHT UPPER QUARDANT
789.32 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP LEFT UPPER QUADRANT
789.33 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP RIGHT LOWER QUADRANT
789.34 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP LEFT LOWER QUADRANT
789.35 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP PERIUMBILIC
789.36 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP EPIGASTRIC
789.37 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP GENERALIZED
789.39 ABDOMINAL OR PELVIC SWELLING MASS OR LUMP OTHER SPECIFIED SITE
789.51 MALIGNANT ASCITES
789.59 OTHER ASCITES
789.60 ABDOMINAL TENDERNESS UNSPECIFIED SITE
789.61 ABDOMINAL TENDERNESS RIGHT UPPER QUADRANT
789.62 ABDOMINAL TENDERNESS LEFT UPPER QUADRANT
789.63 ABDOMINAL TENDERNESS RIGHT LOWER QUADRANT
789.64 ABDOMINAL TENDERNESS LEFT LOWER QUADRANT
789.65 ABDOMINAL TENDERNESS PERIUMBILIC
789.66 ABDOMINAL TENDERNESS EPIGASTRIC
789.67 ABDOMINAL TENDERNESS GENERALIZED
789.69 ABDOMINAL TENDERNESS OTHER SPECIFIED SITE
790.5 OTHER NONSPECIFIC ABNORMAL SERUM ENZYME LEVELS
790.99 OTHER ABNORMAL FINDINGS ON EXAMINATION OF BLOOD
792.1 NONSPECIFIC ABNORMAL FINDINGS IN STOOL CONTENTS
793.4 NONSPECIFIC (ABNORMAL) FINDINGS ON RADIOLOGICAL AND OTHER EXAMINATION OF GASTROINTESTINAL TRACT
793.6 NONSPECIFIC (ABNORMAL) FINDINGS ON RADIOLOGICAL AND OTHER EXAMINATION OF ABDOMINAL AREA, INCLUDING RETROPERITONEUM
799.4 CACHEXIA
862.22 INJURY TO ESOPHAGUS WITHOUT OPEN WOUND INTO CAVITY
874.4 OPEN WOUND OF PHARYNX WITHOUT COMPLICATION
874.5 OPEN WOUND OF PHARYNX COMPLICATED
935.1 FOREIGN BODY IN ESOPHAGUS
935.2 FOREIGN BODY IN STOMACH
936 FOREIGN BODY IN INTESTINE AND COLON
938 FOREIGN BODY IN DIGESTIVE SYSTEM UNSPECIFIED
947.0 BURN OF MOUTH AND PHARYNX
947.2 BURN OF ESOPHAGUS
947.3 BURN OF GASTROINTESTINAL TRACT
959.01 OTHER AND UNSPECIFIED INJURY TO HEAD
959.09 OTHER AND UNSPECIFIED INJURY TO FACE AND NECK
983.2 TOXIC EFFECT OF CAUSTIC ALKALIS
983.9 TOXIC EFFECT OF CAUSTIC UNSPECIFIED
990 EFFECTS OF RADIATION UNSPECIFIED
996.82 COMPLICATIONS OF TRANSPLANTED LIVER
997.41 RETAINED CHOLELITHIASIS FOLLOWING CHOLECYSTECTOMY
997.49 OTHER DIGESTIVE SYSTEM COMPLICATIONS
E864.1* ACCIDENTAL POISONING BY ACIDS NOT ELSEWHERE CLASSIFIED
E864.2* ACCIDENTAL POISONING BY CAUSTIC ALKALIS NOT ELSEWHERE CLASSIFIED
E864.3* ACCIDENTAL POISONING BY OTHER SPECIFIED CORROSIVES AND CAUSTICS NOT ELSEWHERE CLASSIFIED
E864.4* ACCIDENTAL POISONING BY UNSPECIFIED CORROSIVES AND CAUSTICS NOT ELSEWHERE CLASSIFIED
E961* ASSAULT BY CORROSIVE OR CAUSTIC SUBSTANCE EXCEPT POISONING
V10.00 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF UNSPECIFIED SITE IN GASTROINTESTINAL TRACT
V10.03 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF ESOPHAGUS
V10.04 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF STOMACH
V10.09 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF OTHER SITES IN GASTROINTESTINAL TRACT
V12.71 PERSONAL HISTORY OF PEPTIC ULCER DISEASE
V12.72 PERSONAL HISTORY OF COLONIC POLYPS
V12.79 PERSONAL HISTORY OF OTHER SPECIFIED DIGESTIVE SYSTEM DISEASES
V18.51 FAMILY HISTORY, COLONIC POLYPS
V18.59 FAMILY HISTORY, OTHER DIGESTIVE DISORDERS
V55.1 ATTENTION TO GASTROSTOMY
V58.61 LONG-TERM (CURRENT) USE OF ANTICOAGULANTS
V58.64 LONG-TERM (CURRENT) USE OF NONSTEROIDAL ANTI-INFLAMMATORIES
V58.69 LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS
V69.1 INAPPROPRIATE DIET AND EATING HABITS
* According to the ICD-9-CM book, diagnosis codes E864.1, E864.2, E864.3, E864.4 and E961 are secondary diagnosis codes and should not be billed as the primary diagnosis.
Documentation Requirements
• The patient’s medical record (e.g., history and physical, office/progress notes, procedure report) maintained by the ordering/referring physician must clearly indicate the reason for the EGD.
o Also, the results of the EGD must be included in the patient’s medical record.
• The CMS Manual System, Pub. 100-8, Program Integrity Manual, Chapter 13, Section 5.1 (http://www.cms.hhs.gov/manuals/downloads/pim83c13.pdf) outlines that "reasonable and necessary" services are "ordered and/or furnished by qualified personnel."
o A qualified physician for this service/procedure is defined as follows:
A) Physician is properly enrolled in Medicare.
B) Training and expertise
• Must have been acquired within the framework of an accredited residency and/or fellowship program in the applicable specialty/subspecialty in the United States.
Or
• Must reflect equivalent education, training, and expertise endorsed by an academic institution in the United States and/or by the applicable specialty/subspecialty society in the United States.
o This service will be considered medically reasonable and necessary only if performed by providers of gastroenterology services, or other providers who have specialized training and expertise in performing the procedure in question.
Treatment Logic:
• Upper intestinal endoscopy is performed with a lighted, flexible, fiberoptic instrument passed through the cricopharynx.
o The patient receives conscious sedation.
o A topical anesthetic is sometimes applied to the posterior pharynx.
o Direct visualization of the entire esophagus, stomach, and duodenum (to the junction of the second and third portions) can be accomplished easily with modern instruments that are less than 12mm in diameter.
o Esophagogastroduodenoscopy (EGD) is a technique utilized to examine, obtain samples, and in some instances, to treat pathological conditions.
• Diagnostic observations are made concerning focal benign or malignant lesions, diffuse mucosal changes, luminal obstruction, motility, and extrinsic compression by contiguous structures.
• A diagnostic EGD allows the examiner to visualize abnormalities detectable by the technique and to photograph, biopsy, and/or remove lesions as appropriate.
• The purpose of the therapeutic EGD is to
o Manage hemorrhage.
o Remove foreign bodies and neoplastic growths.
o To relieve obstruction due to stricture, malignancy.
o Other causes through dilatation or the placement of stents.
o Assist in the placement of percutaneous gastrostomy tubes.
Sources of Information and Basis for Decision
American Society of Gastrointestinal Endoscopy. Appropriate use of gastrointestinal endoscopy. Gastrointestinal Endoscopy, 52(6) 831-7.
Cappell, M.S., & Friedel, D. (2002). The role of esophagogastroduodenoscopy in the diagnosis and management of upper gastrointestinal disorders. The Medical Clinics of North America 86(6) pg 1165-1216.
FCSO LCD 29167, 10/01/2011, Diagnostic and Therapeutic Esophagogastroduodenoscopy. The official local coverage determination (LCD) is the version on the Medicare coverage database at www.cms.gov/medicare-coverage-database/.
AMA CPT Copyright Statement
CPT codes, descriptions and other data only are copyright 2011 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply.
CMS LCD DIAGNOSTIC AND THERAPEUTIC ESOPHAGOGASTRODUODENOSCOPY